1. Tranzyme Pharma Inc. (7 from 19 patents)

2. Ocera Therapeutics, Inc. (2 from 26 patents)

3. Socpra Sciences Sante Et Humaines S.e.c. (1 from 10 patents)

1. 9809621 - Stable peptide-based PACE4 inhibitors

2. 9409945 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery

3. 9018419 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery

4. 8557765 - Spatially-defined macrocycles incorporating peptide bond surrogates

5. 8188216 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery

6. 8022252 - Spatially-defined macrocyclic compounds useful for drug discovery

7. 8008440 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery

8. 7550431 - Spatially-defined macrocycles incorporating peptide bond surrogates

9. 7452862 - Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists

10. 7169899 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery